Five time European champion and British record-holding athlete, Laura Muir MRCVS, will be in conversation with Gudrun Ravetz and Rob Pope for a keynote session at the virtual event. The line-up also includes Bake-Off star, Rosie Brandreth-Poynter, alongside a number of other expert session leaders for personal development, baking, exercise, crafts and social elements.
The day long programme will start with a run, meditation or yoga. The plenary sessions and workshops include topics such as change management, establishing a ‘new normal', and how to build wellbeing into daily life.
Wellvet co-founder Ru Tipney said: "We're delighted to host an event which brings together so many amazing people to lead valuable - and potentially life-changing sessions - for delegates. We have content for everyone, from student sessions to workshops designed for practice managers and owners."
To include a social aspect, the virtual conference platform provides opportunities for networking and connecting with fellow delegates during and after the event. Ru said: "The vibe we've had at the last two WellVet events has been pretty special. WellVet works because of the mutual encouragement, openness and support of delegates. We're delighted to have found a platform to give a rich social experience alongside all the great content."
The content and networking functions are available for a year after the event and the organisers are keen to stress there's no need to sit through the whole day in one go. Delegates are invited to dip in and out, revisit sessions, and connect with others afterwards. Tickets are subsidised at £40 for a full delegate pass and £10 for students and new graduates.
For more information and to buy tickets, visit: www.wellvet.co.uk
The survey, which is being carried out throughout June, was also conducted back in 2016 and is now being repeated to identify any developments and outcomes that have been made over the past four years, a time in which several new epilepsy management options have emerged.
The survey asks vets to prioritise how important they feel different areas of epilepsy research are and assess how much they think new therapies might improve epileptic dogs’ lives. This includes emerging therapies like MCT oil, cannabidiol oil, vagus nerve stimulation and transcranial magnetic stimulation, for which studies are currently being conducted across the globe.
The aim of the survey is to identify the priorities for future research for owners, vets and neurologists alike, and to see if there are any differences in their priorities.
Dr Rowena Packer, BBSRC Research Fellow and research lead in canine epilepsy at the RVC, said: "This survey was inspired by similar prioritisation activities undertaken by the International League Against Epilepsy (ILAE) for human epilepsy patients. At the RVC, we believe that the benefits of such an open approach can be truly valuable for veterinary medicine too, and ensure a diversity of views influence future epilepsy priorities."
Dr Gareth Jones, Small Animal Intern at the RVC who is running the study, said: "While many have already undertaken the survey, we are keen to hear from more participants so I would like to implore any general practice vets to please help contribute to our work by taking part in our short survey."
To take part in this survey please visit www.rvc.uk.com/epilepsy-future, and do share this news story with colleagues. If you have any questions about the research, e-mail Dr Gareth Jones atgjones1@rvc.ac.uk.
To enter the draw, visit http://www.noble-futures.com/veterinaryCPDgiveaway before the 31st March 2021 and complete the form.
There are ten £250 vouchers for Improve's modular programmes and fifty £50 vouchers for its Practical Surgery and Ultrasound short courses up for grabs.
Tony Noble, Managing Director at Noble Futures said: "At Noble Futures, we care deeply about the veterinary profession.
"Those who work within it are at the heart of our business and we are dedicated to looking after those that work in our industry.
"Recently we made the exciting move into recruitment for clinical veterinary roles, to support our long-standing success in recruitment for industry-based roles and with our huge £5,000 Improve International CPD Giveaway we are looking to give something back to the brilliant veterinary surgeons to whom we owe so much, not only for being at the heart of our business but also for the care and protection that they provide to the many animals in our lives."
The company points to research which found that 89% of the veterinary profession wants to play a more active role in the sustainability agenda1.
For that reason, Boehringer says it put sustainability at the heart of Aservo EquiHaler, which uses no propellant gasses and the container for which is made from up to 50% recycled materials.
Now Boehringer has launched the first recycling programme for a prescription medicine in the UK to support the responsible disposal of the Aservo EquiHaler.
To join the programme, you need to visit: https://equihaler.uk/recycling, set up a TerraCycle account and register your practice. Boehringer says it only takes 10 minutes.
Once signed-up, a Boehringer Ingelheim Territory Manager will arrange for a collection box to be delivered, along with supporting practice display posters. When the box is full, there is a free pick-up service.
Practices that sign-up for the programme before 31st July 2021 will be entered into a prize draw, with the chance to win a year’s supply of ethically-sourced chocolate for their practice.
Reference:
Dechra Veterinary Products, manufacturer and distributor of Equipalazone®, has launched a new website with up-to-date advice and guidance on the subject of equine pain management for horse owners: http://www.equinepainmatters.com/
Dechra says the website offers owners a place to go for information about pain in their horse including causes, diagnosis and the tools and techniques that their vet may use to treat pain. Owners will also be able to download anatomy charts and information leaflets on topics such as pain management, lameness, anaesthesia, sedation, euthanasia, the importance of microchipping and wound management.
Larry King, equine product manager at Dechra said: "This website is great for horse owners as they now have one place to go for information about equine pain matters. It will help them gain a better understanding of managing pain in their horses and the critical role that their vet plays in this area. Veterinary practices can also refer owners to it to support their consultation. This is the first website to put all this information together, so we are sure it will be popular.
"Cards with the new website address are available for practices to hand out to clients. "The website allows clients to browse the site in the comfort of their own home and is also ideal for practices with limited storage space for client information materials."
Dechra also encourages practices that have their own websites to link directly to www.equinepainmatters.com. Practices can order hand-out cards by contacting Dechra on 01743 441632 or email marketing@dechra.com.
Ceva Animal Health has launched its 2013 ReprodAction desktop calendar, with a droll take on cycling cows.
The calendar is available free of charge to vet practices.
If you haven't received your calendar yet, contact Ceva Animal Health on 01494 781510 or email cevauk@ceva.com.
The meeting follows growing concerns expressed both within the profession and in the national media about the shortage of veterinary surgeons in the UK.
Lizzie Lockett, RCVS CEO (pictured right), said: “Workforce shortages within the veterinary sector has been a concern for some time, however, in the past few months there has been a ‘perfect storm’ of circumstances, which have come together to exacerbate the problem. The issues include the ongoing impact of the pandemic, burnout and fatigue within the profession; the UK’s exit from the European Union, which has seen a significant reduction in the number of EU vets joining the Register as well as an associated increase in the need for veterinary certification; and an increase in pet ownership, and therefore demand for veterinary services, over the course of the pandemic."
In advance of the meeting, which is due to be help in November, the College will be conducting research to better gauge the extent of the problem both nationally and regionally.
The meeting will then consider how recruitment, retention and return to work might address the problem.
Lizzie added: “While there has already been a lot of focus and discussions around recruitment and retention, something less spoken about is return, and the summit will consider the reasons why members of the profession may move away from clinical practice, and if there’s more scope for different ways of working that could bring people back into clinical practice.
“Ahead of the summit we will be reviewing all the latest data that we and other organisations have shared to better understand the gap between capacity and demand, the push and pull factors on decisions to either join or leave clinical practice and build a more evidence-based picture of veterinary workforce trends.”
The summit itself, the date of which is yet to be confirmed, will involve key veterinary stakeholders including the veterinary schools, veterinary employers and representative bodies, coming together to ensure that there will be a joined-up approach in finding solutions to the issues confronting the profession.
Lizzie said: “It may not necessarily be easy to identify all the solutions in one day, and they won’t all come from the RCVS, but opening up the conversation and getting the professions focused on taking appropriate action is an important first step.”
Meanwhile, RCVS President Kate Richards this week wrote to all vets and nurses to reassure them them that the RCVS was aware of the problem and the additional pressures they are under as a result.
In the letter she wrote: “In the face of current shortages, I would like to stress that we support practice teams in prioritising cases strictly according to the health and welfare needs of their patients, and in informing their clients of the need to do so.
“We would also urge veterinary surgeons to share their caseload as much as possible, delegating permitted procedures to their veterinary nurse colleagues wherever appropriate to do so.
"And, we would like to remind veterinary surgeons that their current 24/7 emergency cover obligations, as set out in the RCVS Code of Professional Conduct, are limited only to taking steps to provide 24-hour emergency first-aid and pain relief to animals according to their skills and the specific situation."
She also added that, while members of the profession may be anxious about a potential increase in the number of concerns being raised by clients because they are not able to offer the level of service they would ideally like to, the RCVS would always take into account the entire circumstances surrounding a complaint as part of its investigation process.
She also said that the College would also continue to raise awareness amongst animal owners of the acute challenges currently facing veterinary teams around the country, and to request their ongoing patience and understanding.
To assist the profession, a series of FAQs have been produced to help with different situations that vets may encounter at the moment, particularly around the provision of 24/7 emergency cover, and to provide further guidance on delegating procedures to veterinary nurses. These can be found at: www.rcvs.org.uk/news-and-views/news/
The increase, which was approved by the Privy Council on Thursday 2 March, will mean that the standard annual renewal fee for UK-practising veterinary surgeons (which must be paid on or before 1 April 2023) will increase by £15 to £379.
The full list of RCVS fees can be found at www.rcvs.org.uk/how-we-work/fees
Lizzie Lockett, RCVS CEO, said: “We are proud that all throughout the pandemic period, when we know that many were struggling, we managed to keep our fees at the same level in the 2020/21, 2021/22, and 2022/23 fee years.
“The increase that we proposed to the Privy Council is very modest, particularly in comparison to the overall levels of inflation that the British economy has experienced over the past year, which has had an impact on our costs.
“While we appreciate that any rise in fee levels will not be welcomed by everyone, we can assure all members of the professions that we are continuing to use our income prudently and with oversight from our Audit & Risk and Finance & Resources Committees.”
As the increase has been confirmed by the Privy Council, annual renewal fee notifications will be sent to all veterinary surgeons in early March.
The event, sponsored by Provet Cloud, will include interactive workshop sessions on ‘Finding Flexible Working Solutions’, ‘Financial Security and Negotiation Skills’, and ‘Developing Your Personal Brand’.
Women from all areas of the veterinary industry will also be sharing their inspirational career stories.
The speaker line-up for the event includes Flexee’s Silvia Janska, who takes a look at ‘Finding Flexible Working Solutions’, including how they can be implemented in practice to empower individuals and teams, and benefit the business.
Katie Ford and Paul Horwood from VetYou, will be addressing overcoming barriers in talking about, navigating, and creating security with money to arm delegates with negotiation tools and useable resources in their workshop session on ‘Financial Security and Negotiation Skills’
Hamzah Malik from Regent Animal Health will lead a workshop on ‘Developing Your Personal Brand’ to build delegates’ confidence in ways to explore and articulate personal identity and strengths, and apply brand marketing principles to boost career success.
The event will also feature ‘Seeing is Believing’ breakout sessions with female speakers from all spheres of veterinary practice, business, industry, nursing and education, sharing their career stories and taking part in Q&A sessions.
The event is suited to all those thinking about the next career step, considering leadership roles or already working within leadership positions in the veterinary sector.
Veterinary professionals and students can take advantage of an early-bird rate until 20th November.
For more information and to register for the event, visit: https://eu.eventscloud.com/website/7528/home/
The event will offer vets and vet nurses six hours of CPD across five streams, covering topics such as initial fracture treatment, stick injury management, post-op orthopaedic patient care, and handling clinical complaints.
Simon Hagley, an Emergency and Critical Care specialist at Vets Now Manchester, has helped develop the program and will run a session on acute kidney injury.
He said: "We have one of the largest emergency caseloads in the country, therefore we’re well placed to share best practice with the profession to enable vets and vet nurses to feel confident when dealing with emergency cases. "
There will be 23 lectures over the course of the day, across five streams: CPR, Vet Stream, Vet Nurses Stream, Client and Colleague Communication, and Pathology.
The sessions will be delivered by experienced Vets Now clinicians, dedicated nurses, communication experts, and VPG experts.
Later in the year, the Vets Now 24/7 hospital in Glasgow will be offering free evening CPD events at the Hilton Doubletree, Westerwood, all focussing on ECC.
The first of these events, on 05 September 2024 will see Lead OOH Veterinary Surgeon John Sheppard from Vets Now, Glasgow run an out-of-hours session on ‘What happens after dark, shouldn’t leave you in the dark’.
The Manchester event is priced at £80+VAT per person, which includes refreshments, lunch, and on-site parking.
https://www.vets-now.com/professionals/vet-cpd-events-courses.
Virbac Animal Health has launched an enhanced version of its flea and tick spot-on Effipro (fipronil) to help pet owners master the art of 'spotonologyTM - a Maureen-Lipmanesque term the company has coined to describe the optimum application of a spot on treatment.
Effipro is now presented in a clear pipette featuring 'Drop-lock' technology to provide precise finger tip control of the flow of liquid with no risk of drip or leakage. The pipette has also been redesigned to ensure it is simple to open and that users can easily check that all the treatment has been dispensed.
Virbac says Effipro is priced to offer an effective but affordable solution to parasite control. It is presented in client packs of four pipettes and in practice packs of 24 to offer flexible dispensing opportunities. It is also available in a spray form.
Victoria Hudson, Product Manager at Virbac, said: "Parasite control is a key revenue generator for many practices. It also presents a great opportunity to create loyal, bonded clients as fleas and ticks cause great concern to pet owners.
"Effipro is already a popular product but we know that some owners find using spot-ons difficult and worry about the risk of the liquid getting on to their fingers or on furniture, particularly if their pets move around while the treatment is being applied.
"With this in mind, we've taken a fresh look at the technology of spot-ons in order to ensure that we're providing a solution which is as simple and hassle-free as possible. As a first step, we've redesigned our pipette. Our unique Drop-lock technology means that owners can start or stop the flow of liquid with their finger tips, giving them full control over where and when the product is applied. The new see-through design and enhanced opening mechanism also make the new version of Effipro more convenient to use.
"We've had great feedback from practices which have trialled the product and believe it represents a significant step forward for users of spot-ons. We are, of course, providing a range of support materials and product promotions to support its launch and look forward to working with our customers to ensure that their clients become expert and enthusiastic 'Spot.on.ologists' during 2012.
For further information about Effipro contact your Territory Manager or call Virbac on 01359 243243.
The RCVS has launched a survey to discover what the profession thinks it does well and what it could improve upon.
The confidential online survey asks about your recent interactions with the College, what you think the organisation does well and what can be improved upon.
The survey is one of several activities that the College is undertaking as part of its First-Rate Regulator initiative. Others include a survey amongst those who have made complaints; research amongst RCVS staff and Council / VN Council members; in-depth phone interviews with veterinary surgeons, veterinary nurses and practice managers; and, questionnaires aimed at stakeholder organisations that work regularly with the College.
Desk-based research is also being carried out, to see how the RCVS shapes up when compared to other similar regulators, both in the UK and overseas.
Following this evidence-gathering stage, an assessment will be made about where gaps exist between how the College performs and what it ought to be achieving, together with recommendations for change.
Nick Stace, RCVS CEO said: "Becoming a first-rate regulator is the aim, building on the good things we do, and challenging ourselves to be better where we fall short."
"Although the RCVS has a long and proud history, we also need to have a sustainable future. Careful scrutiny of what we do, and how we can improve, will ensure this. I would urge all members of the veterinary team to take this unique opportunity to help improve the regulation of their professions."
The survey closes on 4 January 2013. All veterinary surgeons and veterinary nurses for whom the RCVS holds unique email addresses will be sent a link to the survey. Others are invited to visit www.rcvs.org.uk/firstratesurvey to take part. Practice managers, and student vets and VNs are also encouraged to complete the survey. Individuals who are not veterinary surgeons, nurses, students or practice managers, and who have views about how the College could improve, are invited to contact Nick Stace on nick@rcvs.org.uk.
In contrast to the British Veterinary Association, The National Office of Animal Health (NOAH) has welcomed the decision by DEFRA not to proceed with the proposal contained in the draft Veterinary Medicines Regulations 2010 to prohibit the advertising of antimicrobials to farmers.
NOAH says it believes the proposal would have had a negative effect on farmers' ability to maintain their knowledge and awareness of animal health and welfare issues, and did not believe that it would reduce antimicrobial resistance profiles.
NOAH chief executive Phil Sketchley said: "Farmers, as professional producers of food, need to be kept well briefed on the antimicrobials they use, following prescription by their veterinary surgeons. Promotion by our members plays a key role in this and in educating farmers about animal welfare and disease."
NOAH members follow rigid rules on advertising and promotion through the longstanding Code of Practice for the Promotion of Animal Medicines.
Phil added: "The NOAH Code already goes beyond the Veterinary Medicines Regulations and is reviewed each year - this year we will be particularly looking to ensure that it fully reflects the industry's commitment to disease education and information on responsible use, particularly in relation to antimicrobial promotion. We have planned, at our Code review meeting in February, further discussions within NOAH and with the VMD to finalise how this can best be achieved.
"Importantly we must always remember that antimicrobial medicines for all animals are POM-V, meaning they have to be prescribed by a veterinary surgeon, and therefore it should be the vet who makes the decision on whether an antibiotic is needed. If such therapy is indicated, the most appropriate antibiotic for an animal or group of animals is selected by the veterinary surgeon based on the clinical signs shown, the current disease situation on the farm and in the area and where appropriate and feasible, is based on bacterial culture and sensitivity testing."
Using promotion to encourage responsible use, NOAH launched its 'Use Medicines Responsibly' campaign in 2009. A recommendation was made that members include a strap line on promotional material advising users to 'use medicines responsibly'.
NOAH was a founder member of the Responsible Use of Medicines in Agriculture Alliance (RUMA) and continues to be a strong contributor to and supporter of RUMA's communications to farmers including the antimicrobial guidelines. These guidelines are not intended to influence the veterinary surgeon's decision to prescribe but help support ways that the veterinary surgeon and farmer can work together to reduce the need to prescribe antimicrobials whilst ensuring they are used responsibly once prescribed in line with the principle of 'as little as possible but as much as necessary'.
Phil said: "Antibiotics are essential for the health and welfare of the UK's livestock population. NOAH accepts that antimicrobial resistance is a serious and growing subject of discussion for the medical and veterinary professions and we need to continue to take this matter seriously."
201 practices took part in the survey between 25th February and 4th March 2021. The main findings were:
Lizzie Lockett, RCVS CEO, said: “Although this survey took place in the midst of the lockdown and before the schools re-opened, there were some positive results here around staffing and the financial situation for practices. Hopefully this will mean that, as the restrictions ease going from spring into summer, many practices and practice staff will be in a position to return to a near-normal level of service and business.
"There were, however, still a few areas of concern, some of which will hopefully be resolved by the forthcoming easing of restrictions, for example, the difficulty in obtaining independent witnesses for the destruction of controlled drugs, with some 34% of practices reporting difficulties, compared to 20% in December.
“Once again, I would like to thank all those practices who responded to this and previous surveys, and continue to provide invaluable evidence and feedback about the current state of veterinary practice.”
The full results of the survey can be downloaded at: www.rcvs.org.uk/publications
VetSurgeon.org has launched a new register of veterinary locums as a resource for practices that need to find a locum quickly and at no cost.
Veterinary locums can add themselves to the register free of charge, and include full details of the service they offer.
Practices that need a locum can then search the register by area. After they've used the locum, they are encouraged to comment beneath the locum's entry on the register.
At the time of writing, about a dozen locums have added their details to the register, so it's still early days. Hopefully, however, this will grow into a really valuable resource for both practices and locums.
To add your name to the register, click here and follow the instructions linked to from the right hand side.
Hill’s Prescription Diet Canine r/d has been reformulated following new findings regarding the role of protein in weight loss and the development of new fibre technology.
According to Hill's, trials of the new formulation resulted in some impressive results, with individual overweight animals losing at least 22% of their body fat in 8 weeks while still maintaining muscle mass.
In addition, the company has developed a range of support measures to help raise awareness about obesity and encourage pet owners to come forward. There's a new website: http://www.%20hillsweightloss.co.uk/ containing tips on weight loss and e-mailed reminders about returning to the surgery for weight checks; a pet passport containing information on helping the pet live a longer and healthier life, an anatomy poster that describes the dangers of excess weight gain and a practice display materials kit. Libby Sheridan, Veterinary Affairs Manager at Hill’s, “It can be time consuming to put together a really good wall or table display. This kit offers the opportunity for use in its entirety, while also giving scope to add individual elements for those who want to customize the display further.”
Hill’s Prescription Diet Canine r/d will be available in 1.5Kg, 4Kg and 12Kg bags. The recipe of the current 350g can remains unchanged.
For more information call Hill’s Customer Service on 0800 282 438 or (ROI) 1-800 626002.
Elanco Companion Animal Health has announced that Comfortis (spinosad) flavoured chewable flea control tablets have been licensed for cats.
In addition, the company has extended its range with the addition of two new sizes for toy dogs and smaller cats.
Comfortis chewable tablets for dogs and cats are fast-acting, monthly oral adulticides that start to kill fleas in cats and dogs in 30 minutes and, according to Elanco, rapidly achieve 100% efficacy.
Comfortis chewable tablets for dogs and cats kill adult fleas for a month and Elanco says the fast speed of kill means that adult fleas are killed before they can lay eggs, making Comfortis effective in preventing new infestations.
Patrick Bourdeau, Dip ECVD-Dip EVPC, of the Veterinary School of Nantes (Oniris), France said: "Comfortis offers a highly effective format to those owners who have not had relief with other forms of flea control. The tablet offers a high level of convenience to owners to ensure both cats and dogs receive immediate relief from flea infestation.
"This is especially pertinent to the nearly 30% of cat owners who have reported problems with administering other forms of flea treatment, including spot-ons, which can have an effect on efficacy1. This includes the animal escaping when they sense a topical treatment is about to be administered or during actual administration3".
He added: "Comfortis is a highly effective treatment for flea control for cats and dogs, and one that will aid with compliance because it is easier to administer correctly."
Charlotte Mayne MRCVS, principal and veterinary surgeon at The Mayne Veterinary Clinic in Colchester, Essex, said: "We have used Comfortis chewable tablets for cats in practice, with 94% of clients who were prescribed the product for their pet being able to administer Comfortis and 80% of owners able to give the treatment so easily that they did not need to pill it2. Indeed, all the clients who were able to administer the treatment said they would use it again with comments such as 'it's brilliant - the best product ever' to 'my cat ate it like sweets' and we had 'lots of dead fleas'."
Comfortis chewable tablets for dogs and cats are available in 90mg, 140mg, 270mg and 425mg packs of six. Comfortis chewable tablets for dogs is also available in 665mg, 1040mg and 1620mg packs of six.
For further information on Comfortis, please contact your Elanco Companion Animal Health key account manager or phone 01256 353131.
References
Norbrook Laboratories has announced that Pestigon for Cats, the company's fipronil spot on solution against fleas and ticks, has been granted an extension to its licence which means it is now indicated against the Ixodes ricinus tick.
Previously, the cat product was only indicated for Dermacentor reticulatus.
The Pestigon dog spot on offers efficacy against the Dermacentor reticulatus, Rhipicephalus sanguineus and the Ixodes ricinus tick.
Michelle Jones, Norbrook's Small Animal Brand Manager said: "The extension of our licence for Pestigon in Cats is welcome news. The Ixodes ricinus tick is one of the most common ticks found in the UK. Pet owners need to be aware that choosing a treatment that kills ticks as well as fleas is vital, with ticks potentially spreading diseases such as lyme disease. We are therefore delighted that our Pestigon range now gives cat owners even more protection against fleas and ticks."
Michelle added: "Pestigon is only available through veterinary practices which means that pet owners have to visit their practice to purchase this flea and tick treatment. They can therefore receive expert advice at the point of purchase and discuss any concerns they may have."
Pestigon spot on is available from all wholesalers in packs of 3, 6 and 24. Norbrook also makes a household spray, Permaguard, and a range of customer support materials available from Norbrook Territory Managers.
Image: Ixodes ricinus Richard Bartz
The company says the sessions will help veterinary staff learn more about the condition - which affects up to 20% of dogs in the UK annually1 - the causes and consequences of osteoarthritis pain, the main predisposing risk factors and the impact of chronic pain on central sensitisation.
The CPD will look at what steps practices can take to mitigate animal suffering and increase long-term owner compliance and will encourage practices to look at their current osteoarthritis management strategy.
Kai Crawshaw, Brand Manager at Animalcare, said: "Canine osteoarthritis is a growing concern for UK vets – latest figures suggest that over two million dogs are suffering, based on current population figures.
"Managing these cases can be challenging, but through this lunch and learn session, we aim to support veterinary staff and help them to expand their knowledge and implement an improved approach for managing canine osteoarthritis.’
www.animalcare.co.uk/lunch-and-learn
Reference
In what the company says is a European first, IVC vets will be recognised for the skills they already have, as well as supported to achieve new skills within the GP framework.
The programme is also intended to increase GP's status within the profession, boost confidence, develop ability and provide a clear path for career progression.
Edward Davies BVSc MRCVS, IVC's new Aspirational GP Lead, said: "The plethora of skills a GP vet has is unparalleled when you look at other professions.
“This programme is about recognising the core and expansive knowledge sets we as GP vets possess, not just at an individual level, but an organisational and professional level.”
An initial two cohorts of up to 20-30 vets from across the business will take part over the next 12 months, and the expectation is that it will take around two years for every cohort to complete.
The programme is structured around a portfolio-based assessment by peers, with six core and three elective categories.
The core section includes the elements seen as fundamental to being a successful GP vet, complimented by the individual vet’s selection of three elective modules which best fit their clinical interests.
IVC says it plans for the GP Vet Futures Award to be externally accredited.
Ceva Animal Health has launched a competition - open to veterinary surgeons and nurses - to support Cardalis (benazepril and spironolactone), its dual-acting treatment for heart failure in dogs.
To enter the competition, which will run till the end of April, visit www.cardaliscompetition.co.uk and answer 4 questions about Cardalis. There's a £400 Amazon gift voucher up for grabs.
Fraser Broadfoot, small animal product manager at Ceva Animal Health, said: "Cardalis is proving extremely popular and we are therefore very excited to offer veterinary professionals the chance to win a great prize by sharing their knowledge of the product."
The full day programme includes:
• Gastroprotectants in veterinary medicine – Julien Bazelle• An update on steroid responsive meningitis arteritis and meningoencephalitis of unknown aetiology – Jeremy Rose• An update on feline viral infections – Dr Jane Sykes• Guiding clinical decision making in Cushing’s syndrome – Imogen Schofield• What can’t TKIs be used for? – Aaron Harper• Case experiences – Professor Michael Herrtage
The society is also inviting entries for its Case Report competition, the deadline for which is the 6th March 2020.
The meeting costs £130 for members, £180 for non members and £75 for interns, residents and those graduating in 2020.
For more information and to register, visit: https://www.samsoc.org/meetings/2020-spring-meeting
The ban on gatherings applies to birds at higher risk of avian flu including chickens, turkeys, ducks and geese, and restricts events such as livestock fairs, auctions and bird shows.
Since the disease was declared on 16 December it has now been confirmed all 2,500 birds at the farm have been destroyed, the farm has been disinfected and there have been no subsequent cases reported, though a 3km Protection Zone and a 10km Surveillance Zone around the site remain in place.
The ban is part of the Government’s measures to tackle the disease and reduce the risk of the virus spreading, which includes a requirement to keep all poultry and captive birds housed or otherwise separated from contact with wild birds and advice urging farmers and poultry keepers to ensure strict biosecurity standards.
The ban on gatherings does not apply to pigeons or aviary birds which are at much lower risk of passing the disease to domestic poultry. It will be kept under review and may be lifted or amended if the risk level changes.
Advice from Public Health England remains that the risk to public health from the virus is very low. The Food Standards Agency has also made clear bird flu does not pose a food safety risk for UK consumers. There is not anticipated to be any impact on the supplies of turkeys or other birds over Christmas.
Chief Veterinary Officer, Nigel Gibbens, said: "While we have seen no further cases of bird flu following the outbreak in Lincolnshire, we must continue to be vigilant and do all we can to protect against this highly pathogenic strain of the disease.
"This ban on gatherings is a proportionate step that will help protect our farmers and bird keepers from seeing their flocks infected with this disease that can have a devastating impact on poultry.
"The risk to human health continues to be very low and there is no impact on the food chain, but infection at a gathering could lead to rapid dispersal of infection to kept birds in many locations.
"Our Avian Influenza Prevention Zone remains in place across the country and anyone who has regular contact with birds should stay alert for signs of disease, maintain the highest biosecurity standards and take all reasonable steps to minimise contact between poultry and wild birds."
Bird keepers should report suspected disease immediately and must maintain high biosecurity standards by:
Biobest is highlighting the benefits of using its canine prostate specific arginine esterase (CPSE) test to differentiate between those dogs which have benign prostatic hyperplasia and those suffering more serious conditions, such as neoplasia.
Benign prostatic hyperplasia is a common condition of entire dogs with over 50% of dogs over 5 years of showing histological evidence of BPH.
Paul Burr MRCVS from Biobest said: "While the clinical stages of prostatic disease are not difficult to diagnose, differentiating BPH from other causes of prostatic disease such as prostatic cysts, prostatitis, prostatic abscesses or neoplasia is less simple. Traditionally further investigation would include bacteriology and cytology on a prostatic wash or final needle aspirate, and prostatic ultrasonography."
Although the CPSE test has been available for a couple of years now, Paul says the benefits of the test have not thus far been well-explained: "I think most vets probably think it's just a test for Prostatic Disease, something which is easy enough to diagnose without testing.
"While the test can be used as part of an annual check up to look for pre-clinical BPH in entire male dogs, it's real value is that it is a simple, convenient non-invasive blood test that helps determine whether a dog presenting with signs of prostatic disease is most likely to be suffering from BPH or a more serious condition that requires further investigation."
For more information about the CPSE test, contact Biobest on 0131 440 2628 or email enquiry@biobest.co.uk.
The operation of the equipment is being overseen by Dr Rodney Ayl, a specialist in both medical and radiation oncology. He said: "The need for protection of personnel during preparation of cytotoxic drugs presents the most significant obstacle to the safe provision of chemotherapy, as most practices are not equipped with an appropriate biosafety cabinet. This is especially true when there is a high case-load of chemotherapy patients."
Dr Ayl says the dangers of repeatedly handling and administering cancer drugs can be severe. He added: “The likelihood of drug exposure must be taken into account when considering the safety of personnel who handle cytotoxic drugs.
"The cumulative toxicity to personnel that arises from repeated contact with these drugs can cause health problems in the nursing staff that are beyond those expected in the patient.
"The main routes of personnel exposure to cytotoxic drugs are by aerosolisation or by absorption through skin.
"Both types of exposure can occur when preparing drugs for administration. The act of withdrawing cytotoxic drug from the vial into a syringe is generally the step that presents personnel with the greatest potential for exposure to a high concentration of drug.
"Ideally, personnel are optimally protected from drug exposure, and patients are protected from contamination of the product, by the use of a laminar flow biosafety cabinet (BCS) during drug preparation, regardless of whether a closed delivery system is used.
"The Envair CytoFAST BSC has been designed to guarantee the product, personnel and environmental protection.
"It belongs to the latest generation of laminar airflow systems and is built to the highest quality to guarantee the strictest safety standards - and the safety of our people is paramount at Paragon."